Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in diuretic-resistant acute heart failure
NCT04331132Unknown
- Sponsor
- Gia Dinh People Hospital
- Start
- Dec 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tolvaptan in Acute Heart Failure (AHF) (2 arms), sponsored by Gia Dinh People Hospital. Primary endpoint: Cumulative urine volume output at 48h after randomization. Status: unknown.
02
Drugs
tolvaptan
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT04331132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331132.